<VariationArchive VariationID="2427367" VariationName="NC_000002.11:g.(?_232952187)_(233201340_?)del" VariationType="Deletion" Accession="VCV002427367" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1950143" VariationID="2427367">
      <GeneList>
        <Gene Symbol="DIS3L2" FullName="DIS3 like 3'-5' exoribonuclease 2" GeneID="129563" HGNC_ID="HGNC:28648" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q37.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="231961713" stop="232344350" display_start="231961713" display_stop="232344350" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="232826292" stop="233208677" display_start="232826292" display_stop="233208677" Strand="+" />
          </Location>
          <OMIM>614184</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DIS3L2">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DIS3L2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000002.11:g.(?_232952187)_(233201340_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q37.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="232952187" innerStop="233201340" display_start="232952187" display_stop="233201340" variantLength="249154" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_232952187)_(233201340_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_232952187)_(233201340_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.11:g.(?_232952187)_(233201340_?)del AND Perlman syndrome" Accession="RCV003113696" Version="4">
        <ClassifiedConditionList TraitSetID="7919">
          <ClassifiedCondition DB="MedGen" ID="C0796113">Perlman syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-17" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-13" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22306653</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23486540</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7919" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5853" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Renal hamartomas nephroblastomatosis and fetal gigantism</ElementValue>
                <XRef ID="Renal+hamartomas+nephroblastomatosis+and+fetal+gigantism/6206" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Perlman syndrome</ElementValue>
                <XRef ID="MONDO:0009965" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nephroblastomatosis fetal ascites macrosomia and wilms tumor</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PRLMNS</ElementValue>
                <XRef Type="MIM" ID="267000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3936" />
                <XRef ID="3936" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <XRef ID="2849" DB="Orphanet" />
              <XRef ID="C0796113" DB="MedGen" />
              <XRef ID="MONDO:0009965" DB="MONDO" />
              <XRef Type="MIM" ID="267000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7076370" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2023-02-13">
        <ClinVarSubmissionID localKey="NM_152383.4_2_Deletion (exons 6-21)|MedGen:C0796113" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003796775" DateUpdated="2024-06-09" DateCreated="2023-02-13" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22306653</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23486540</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the DIS3L2 protein in which other variant(s) (deletion of exon 9) have been determined to be pathogenic (PMID: 22306653, 23486540). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with DIS3L2-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 6-21 of the DIS3L2 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DIS3L2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_232952187)_(233201340_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796113" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7076370" TraitType="Disease" MappingType="XRef" MappingValue="C0796113" MappingRef="MedGen">
        <MedGen CUI="C0796113" Name="Perlman syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

